Tenaten in the therapy of patients with moderate cognitive disorders

Tenoten is a new anxiolytic and anti-depressive medicine based on antibodies to the brain-specific calcium-regulated modulator S-100b protein. Experimental studies have shown its impact on mechanisms of neuronal plasticity and manifestations of higher nervous activity such as learning ability, memory, and condition of affective-will functions. In the clinical sense, tenoten can compete with amitriptillin, sertralen, and phenasepam but, in contrast to them, it does not have any strong sedative and relaxing effect. Studies conducted showed a reliable improvement of executive functions of frontal brain parts. Tenoten is recommended for use not only at the stage of moderate cognitive disorders, but also in the therapy of apparent vascular brain disorders when a decrease in regulatory functions of anterior parts of the brain is clearly manifested.